Congressional investigators are expanding their inquiry into ActBlue, a Democratic fundraising organization, focusing on its handling of foreign donations. The Republican chairs of three House committees have requested interviews with five members of ActBlue's board and the production of documents related to allegations of donor fraud. The board members have until June 16 to comply voluntarily. The investigation is centered on whether ActBlue accurately represented its fraud-prevention practices and its management of foreign donations that may have influenced U.S. elections. House Republicans have accused ActBlue of not cooperating with their investigation by withholding documents and lacking transparency regarding potential misrepresentations.
House Administration Committee Chairman Brian Steil, House Oversight Committee Chairman James Comer, and House Judiciary Committee Chairman Jim Jordan expressed concerns that the board may have participated in or been aware of misconduct. ActBlue's CEO, Regina Wallace-Jones, is scheduled to testify before the House Administration Committee on June 10 regarding the platform's vetting of foreign donations. Previous reports indicated that ActBlue's attorneys raised questions about the accuracy of the organization's fraud-prevention descriptions provided to Congress.
ActBlue has denied any wrongdoing and has not faced criminal charges. The organization has characterized the congressional investigation as a Republican effort to undermine its role in the Democratic Party's financial structure ahead of the upcoming midterm elections.